These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6240431)

  • 21. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.
    Burgio GR; Ugazio AG; Nespoli L; Marcioni AF; Bottelli AM; Pasquali F
    Eur J Immunol; 1975 Sep; 5(9):600-3. PubMed ID: 11993318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Down syndrome: immunological study in adults (author's transl)].
    Argentiero V; Tavolato B; Bertolissi M; Gentile B; Piazza L
    Riv Patol Nerv Ment; 1979 Jun; 99(5):267-74. PubMed ID: 159484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?
    Cuadrado E; Barrena MJ
    Clin Immunol Immunopathol; 1996 Mar; 78(3):209-14. PubMed ID: 8605695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the immune system in Down's syndrome patients].
    Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V
    Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ["E" and "EAC" rosette tests of peripheral blood in children with Down's syndrome].
    Kobielowa Z; Pietrzyk J; Mytar B; Mitkowska Z
    Pediatr Pol; 1980 May; 55(5):609-15. PubMed ID: 6447268
    [No Abstract]   [Full Text] [Related]  

  • 27. Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome?
    Bartosz G; Soszyński M; Kedziora J
    Cell Biol Int Rep; 1982 Jan; 6(1):73-7. PubMed ID: 6459857
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life span changes in the averaged evoked responses of Down's syndrome and nonretarded persons.
    Callner DA; Dustman RE; Madsen JA; Schenkenberg T; Beck EC
    Am J Ment Defic; 1978 Jan; 82(4):398-405. PubMed ID: 146432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
    Ferro LM; Zola H
    Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on the levels of gamma G, gamma A, gamma M globulins, anti-A and anti-B agglutinins, and antibodies to Escherichia coli in Down's anomaly.
    Adinolfi M; Gardner B; Martin W
    J Clin Pathol; 1967 Nov; 20(6):860-4. PubMed ID: 4177796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal fetal immunological development in Down's syndrome.
    Thilaganathan B; Tsakonas D; Nicolaides K
    Br J Obstet Gynaecol; 1993 Jan; 100(1):60-2. PubMed ID: 8427840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Humoral and cellular immunity in children with Down's syndrome].
    Lukas A; Cesarz E; Lukas W; Sychłowy A; Sliwa F
    Pediatr Pol; 1980 Jan; 55(1):33-40. PubMed ID: 6445054
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunodeficiency in Down's syndrome. Titres of "natural" antibodies to E. coli and rabbit erythrocytes at different ages.
    Ugazio AG; Lanzavecchia A; Jayakar S; Plebani A; Duse M; Burgio GR
    Acta Paediatr Scand; 1978 Nov; 67(6):705-8. PubMed ID: 152559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.
    Meyerovitch J; Antebi F; Greenberg-Dotan S; Bar-Tal O; Hochberg Z
    Arch Dis Child; 2012 Jul; 97(7):595-8. PubMed ID: 22535238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7.
    Catovsky D; Cherchi M; Brookss D; Bradely J; Zola H
    Blood; 1981 Aug; 58(2):406-8. PubMed ID: 6788112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.